Inventor · disambiguated record
Sridaran Natesan
Also filed as: NATESAN SRIDARAN
5 granted patents·7 pending applications·267 citations·filing 1996–2013
84Inventor score
Files withARIAD GENE THERAPEUTICS INC5AVENTIS PHARMA INC2ARIAD PHARMA INC1AUGUST PAUL1GRUENEBERG DORRE1
Top patents by PatentIndex Score
12 records- 0192US6479653B1Compositions and method for regulation of transcriptionARIAD GENE THERAPEUTICS INC·Filed 2000·Granted Nov 12, 2002·50 cites·45 claims
- 0290US6015709ATranscriptional activators, and compositions and uses related theretoARIAD PHARMA INC·Filed 1997·Granted Jan 18, 2000·108 cites·44 claims
- 0386US6117680ACompositions and methods for regulation of transcriptionARIAD GENE THERAPEUTICS INC·Filed 1998·Granted Sep 12, 2000·87 cites·62 claims
- 0468US6306649B1Heterologous transcription factorsARIAD GENE THERAPEUTICS INC·Filed 1996·Granted Oct 23, 2001·22 cites·2 claims
- 0563US8329669B2Composition and method for treatment of tumorsAUGUST PAUL·Filed 2007·Granted Dec 11, 2012·0 cites·19 claims
- 0653US2013252837A1Method for measuring resistance or sensitivity to docetaxelGRUENEBERG DORRE·Filed 2013·Application pending·0 cites
- 0751US2003143731A1Use of heterologous transcription factors in gene therapyARIAD GENE THERAPEUTICS INC·Filed 2001·Application pending·0 cites
- 0849US2009226894A1Method for measuring resistance or sensitivity to docetaxelAVENTIS PHARMA INC·Filed 2005·Application pending·0 cites
- 0947US2013059298A1Composition and Method for Treatment of TumorsSANOFI SA·Filed 2012·Application pending·0 cites
- 1044US2002048792A1Methods and materials for regulated production of proteinsARIAD GENE THERAPEUTICS INC·Filed 2001·Application pending·0 cites
- 1139US2009215876A1Mitotic Progression Genes and Methods of Modulating MitosisKING RANDALL W·Filed 2007·Application pending·0 cites
- 1238US2007280885A1Methods Of Treating Demyelinating DisordersAVENTIS PHARMA INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sridaran Natesan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →